Porous Structures of Microbial-Derived Cellulose In Vivo Implantation

• US 20170258964A1
• Filed: 04/14/2017
• Published: 09/14/2017
• Est. Priority Date: 12/19/2008
• Status: Abandoned Application

• Current Assignee: Depuy Synthes Products Incorporated (Johnson & Johnson)
• Original Assignee: Depuy Synthes Products Incorporated (Johnson & Johnson)
• Inventors: Serafica, Gonzalo, Weinberger, Lauren
• Application Number:
  US15/487,464
• Publication Number:
  US 20170258964A1
• Time in Patent Office: Days
• CPC Class Codes: A61L 15/28 Polysaccharides or their derivatives A61L15/225 takes precedence
• CPC Class Codes: A61L 15/40 containing ingredients of undetermined constitution or reaction products thereof , e.g. plant or animal extracts
• CPC Class Codes: A61L 15/425 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61L 2300/604 Biodegradation
• CPC Class Codes: A61L 2300/64 Animal cells
• CPC Class Codes: A61L 2430/34 for soft tissue reconstruction
• CPC Class Codes: A61L 27/20 Polysaccharides
• CPC Class Codes: A61L 27/3637 characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61L 27/58 Materials at least partially resorbable by the body
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: B29C 67/20 for porous or cellular articles, e.g. of foam plastics, coarse-pored chemical aspects of working up macro-molecular substances to porous or cellular articles C08J9/00
• CPC Class Codes: B29D 7/01 Films or sheets
• CPC Class Codes: B29K 2001/00 Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
• CPC Class Codes: B29L 2007/001 having irregular or rough surfaces treads for tyres B29L2030/002
• CPC Class Codes: C08L 1/02 Cellulose; Modified cellulose
• CPC Class Codes: C12P 19/04 Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
• CPC Class Codes: Y10T 428/249978 Voids specified as micro

Abstract

This invention elates to polysaccharide materials and more particularly to microbial-derived cellulose having the porosity and containing pores of the desired size making it suitable for cellular infiltration during implantation and other desirable properties for medical and surgical applications. The invention also relates to the use of porous microbial-derived cellulose as tissue engineering matrices, human tissue substitutes, and reinforcing scaffolds for regenerating injured tissues and augmenting surgical procedures The invention outlines various methods during and after fermentation to create porous microbial cellulose capable of allowing cell infiltration while preserving the physical properties of the microbial-cellulose.

Claims

1-20. -20. (canceled)

21. A method of producing a porous cellulose sheet for use as an implantable medical device comprising the steps of :

synthesizing microbial-derived cellulose in a bioreactor, wherein the bioreactor comprises protrusions, and wherein the microbial-derived cellulose is synthesized around the protrusions such that a cellulose sheet containing pores is formed;

depyrogenating the porous cellulose sheet,

compressing the porous cellulose sheet; and

,

dehydrating the porous cellulose sheet;

wherein the porous cellulose sheet is configured for use as an implantable medical device.

22. The method of claim 21, wherein the porous cellulose sheet is dehydrated by solvent dehydration.

23. The method of claim 21, wherein the porous cellulose sheet is dehydrated by supercritical drying.

24. The method of claim 21, further comprising chemically oxidizing the porous cellulose sheet.

25. The method of claim 21, further comprising puncturing the porous cellulose sheet with a microneedle array to form holes in the porous cellulose sheet.

26. The method of claim 21, wherein the implantable medical device has a thickness in the range of about 0.1 mm to about 10 mm.

27. The method of claim 21, wherein the average pore diameter of the porous cellulose sheet is in the range of about 100 microns to about 400 microns.

28. The method of claim 25, wherein the average hole size formed by the microneedle array is about 100 microns to about 500 microns.

29. The method of claim 21, wherein the porous cellulose sheet includes a first side and a second side, the second side disposed opposite the first side, and wherein the protrusions are arranged such that the pores are formed only on the first side.

30. The method of claim 21, wherein the porous cellulose sheet includes a first side and a second side, the second side disposed opposite the first side, and wherein the protrusions are arranged such that the pores extend through the first side to the second side.

32. The method of claim 25, wherein the porous cellulose sheet includes a first side and a second side, the second side disposed opposite the first side, and wherein the microneedle array punctures the porous cellulose sheet such that the holes are formed only on the first side.

33. The method of claim 21, wherein the porous cellulose sheet includes a first side and a second side, the second side disposed opposite the first side, and wherein the microneedle array punctures the porous cellulose sheet such that the holes extend through the first side to the second side.

34. The method of claim 21, further comprising seeding the implantable medical device with a cell culture.

35. The method of claim 21, further comprising a second compressing of the porous cellulose sheet.

36. The method of claim 21, further comprising a second dehydrating of the porous cellulose sheet.

37. The method of claim 21, wherein the steps of compressing and dehydrating comprises:

(a) a first compressing of the porous cellulose sheet;

(b) a first dehydrating of the porous cellulose sheet;

(c) a second compressing of the porous cellulose sheet; and

,

(d) a second dehydrating of the porous cellulose sheet.

38. The method of claim 21, wherein dehydrating comprises:

exposing the porous cellulose sheet to a water-soluble organic solvent;

exchanging water within the porous cellulose sheet with the organic solvent; and

removing the organic solvent from the porous cellulose sheet.

39. The method of claim 21, wherein dehydrating comprises:

exposing the porous cellulose sheet to a water-soluble organic solvent;

exchanging water within the porous cellulose sheet with the organic solvent;

immersing the porous cellulose sheet containing organic solvent into a supercritical fluid;

exchanging the organic solvent in the porous cellulose sheet with the supercritical fluid; and

,

removing the supercritical fluid from the porous cellulose sheet.

40. The method of claim 21, wherein compressing the porous cellulose sheet results in the implantable medical device having at least 90% cellulose content by weight.